About stimOS GmbH: stimOS GmbH, a privately held research-company and 13485:2016 certified legal manufacturer, was founded in 2015. stimOS develops innovative technologies and procedures to refine, functionalize and activate implant materials. As a supplier and service provider, stimOS makes this technology available to implant manufacturers. In addition, the company also offers services in the field of product development and certification and develops with the product line spineFuseMBT implants for spinal fusion surgery. About MBT - Mimicking Bone Technology: MBTosseo is stimOS’s patented surface functionalization technology. stimOS developed a covalently bonded 3D continuous biomimetic surface layer, specifically designed for inert implant materials. This development exhibits excellent combinations of surface free energy and mechanical stability. The combination of implant and surface functionalization (MBT) shows high cyto-tolerance for bone constitution and the ingrowth of bone-cells. MBT is (a) biocompatible, (b) avoids infections, (c) preserves healthy bone, (d) stimulates new bone formation, and results in an (e) overall high BIC (bone-to-implant contact), superior to all known surface materials or coating technologies. About High-Five MBT stimOS products for implant surface functionalization under the label MBT are available in different categories: osseo, biocid, dental, active, protect. All stimOS surface functionalization technologies show superiority regarding the growth of bone cells. Comparative data made by the Universities of Constance, Zurich and Charité Berlin demonstrate excellent results for all MBT surface treatments compared to currently available implant materials.